Association between biomarkers of inflammation and dyslipidemia in drug resistant tuberculosis in Uganda
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Association between biomarkers of inflammation and dyslipidemia in drug resistant tuberculosis in Uganda ; volume:23 ; number:1 ; day:1 ; month:3 ; year:2024 ; pages:1-9 ; date:12.2024
Lipids in health and disease ; 23, Heft 1 (1.3.2024), 1-9, 12.2024
- Creator
-
Baluku, Joseph Baruch
Nalwanga, Robinah
Kazibwe, Andrew
Olum, Ronald
Nuwagira, Edwin
Mugenyi, Nathan
Mulindwa, Frank
Bongomin, Felix
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-024-02063-7
- URN
-
urn:nbn:de:101:1-2405052126199.316395681754
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Baluku, Joseph Baruch
- Nalwanga, Robinah
- Kazibwe, Andrew
- Olum, Ronald
- Nuwagira, Edwin
- Mugenyi, Nathan
- Mulindwa, Frank
- Bongomin, Felix
- SpringerLink (Online service)
Other Objects (12)
Predictors of treatment delay among drug resistant tuberculosis patients in Uganda
Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
Multidrug-resistant tuberculosis
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda
Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Diabetes Dyslipidemia
Nomogram to predict multidrug-resistant tuberculosis
Treatment of isoniazid-resistant pulmonary tuberculosis
Tuberculosis out of control : strategies to fight multidrug-resistant tuberculosis
Predictors of treatment delay among drug resistant tuberculosis patients in Uganda
Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
Multidrug-resistant tuberculosis
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda
Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Diabetes Dyslipidemia
Nomogram to predict multidrug-resistant tuberculosis
Treatment of isoniazid-resistant pulmonary tuberculosis
Tuberculosis out of control : strategies to fight multidrug-resistant tuberculosis
Predictors of treatment delay among drug resistant tuberculosis patients in Uganda
Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda
Multidrug-resistant tuberculosis
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda
Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Diabetes Dyslipidemia
Nomogram to predict multidrug-resistant tuberculosis
Treatment of isoniazid-resistant pulmonary tuberculosis